July 2016: A workshop on "Novel approaches to fight bacteria" will take place from 10th to 14th of July 2016 at Jacobs-University in Bremen.
For more information select NEWS and download the flyer. Registration will come soon.
Antimicrobial resistance (AMR) is now a major global public health threat. Despite the recognized need for new antimicrobials for clinical use, the reality that only two new classes of antibiotics have been brought to market in the last 30 years and many drug developers have left the field. ND4BB is part of the “Action plan against the rising threats from Antimicrobial Resistance” adopted by the European Commission in answer to the Council Conclusions and European Parliament resolution to “establish an EU-wide plan to combat AMR.
New Drugs for Bad Bugs aims to join forces between public and private partners in order to bring new antimicrobials closer to patients, to share information and to boost research on improving the uptake (and decreasing the efflux) of antibiotics into Gram-negative bacteria which is one of the greatest challenges facing drug discovery for Gram-negative pathogens.